The plethora of knowledge gained on myelodysplastic syndromes (MDS), a heterogeneous
pre-malignant disorder of hematopoietic stem cells, through sequencing of several pathway …

Myelodysplastic syndrome (MDS) is characterized by an ineffective hematopoiesis with
production of aberrant clones and a high cell apoptosis rate in bone marrow (BM) …

Reciprocal translocations (RecT) and Robertsonian translocations (RobT) are among the
most common chromosomal abnormalities that cause infertility and birth defects …

Myelodysplastic syndromes (MDS) are a group of clonal hematological disease with high
risk of progression to AML. Accurate risk stratification is of importance for the proper …

Background The treatment strategies for Myelodysplastic Syndromes (MDS) are usually
based on the risk stratification system. However, few risk signatures which integrate the …

Genomic instability, microenvironmental aberrations, and somatic mutations contribute to the
phenotype of myelodysplastic syndrome and the risk for transformation to AML. Genes …

The advent of technological development has undoubtedly advanced biological and
molecular inputs for better understanding the heterogeneous hematopoietic pre-malignant …

Myelodysplastic syndromes (MDS) are a group of heterogeneous hematologic diseases.
Chromosomal aberrations are important for the initiation, development, and progression of …

This study aims to investigate the prevalence and distribution of diverse chromosomal
aberrations associated with myelodysplastic syndromes (MDS) in China. Bone marrow …

Myelodysplastic syndromes (MDS) are a group of heterogeneous hematologic
malignancies. This study aims to identify latent chromosomal abnormalities relevant to MDS …